ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call

  Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

• How AI Activates The Full Potential Of Wearables In Clinical Research

  Wearables provide continuous real‑world insights, and AI turns raw sensor data into meaningful evidence. With unified data infrastructure, studies gain more reliable, patient‑centered endpoints.

• EDC Powers End-To-End Data Management In Pharma-Sponsored Trials

  As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.

• Beginner's Guide To 21 CFR Part 11 Compliance

  Computer systems used for clinical trials fall under Food and Drug Administration (FDA) 21 CFR Part 11. While Part 11 is widely known, this blog explains how it fits in with your research software.

• The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems

  Here we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.

• The Impact Of Clinical Trial Payments On Site-Sponsor Relationships

  The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.

• Clinical Trial Technology Report Showcases 2023 Trends: Site Enablement, eISFs, And Integrations

  Dive into six insights to stay on top of the rapidly shifting research industry and to ensure your research organization doesn’t get left behind. 

• Unlocking The Power Of Real-World Evidence In FDA Submissions

  Understand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.

• Building Blocks: The Ultimate Guide To AI In Clinical Trials

  This comprehensive guide provides an authoritative, in-depth look at AI's role in accelerating drug development and improving patient outcomes, with special focus on emerging agentic AI technologies.

• eCOA Risk Management In The Digital Age

  Regulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.